Schiff Andrew N

Schiff Andrew N is listed in filings as Director at Monte Rosa Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 16, 2025, including 5 public disclosures. Recent filings connect the profile to Monte Rosa Therapeutics, Inc. (GLUE) and Aclaris Therapeutics, Inc. (ACRS). The current snapshot covers public activity from Jun 13, 2024 to Jun 16, 2025. Reported amounts are shown as $150.7K to $91.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.